Towards a European Medicines Security Act

A dedicated evaluation framework for value added medicines

Infographic – Medicines Shortages: root causes and policies recommendations

Factsheet – Medicines Shortages: root causes and policies recommendations

<strong><a class=”button small empty” href=”https://www.medicinesforeurope.com/wp-content/uploads/2023/03/factsheet-medicines-shortages-v3-low.pdf”>Open</a></strong>

It’s time to protect our medicines!

Infographic – Medicines Manufacturing

<strong><a class=”button small empty” href=”https://www.medicinesforeurope.com/wp-content/uploads/2023/05/Man-campaign-2022.png”>Open</a></strong>

Final recommendations from “Ensuring equitable and sustainable access to medicines through a secure and resilient supply”

Medicines for Europe, the European off-patent medicines association, and CAFF, the Czech generic and biosimilar medicines association, have organised under the auspices of the Czech Presidency of the Council of the European Union a seminar on 10 November 2022 entitled “Ensuring equitable and sustainable access to medicines through a secure and resilient supply”.

The event has been organised in line with the main objectives stated in the European Commission pharmaceutical and updated industrial strategies for Europe, which have been published setting up clear goals for the European Union that delivers on access, availability and affordability while achieving a great open strategic autonomy, also taking into account the Covid-19 pandemic lesson learned.

 

Open

A Strong European API Industry Can Achieve Strategic Autonomy of the EU Health System

One- Pager: New pricing models for generic medicines

How can we ensure a sustainable healthcare system while safeguarding continuous patient access to medicines?

Open